Skip to main content

Table 1 Univariate analysis comparing 26 visits with environmental contamination with the 112 visits without environmental contamination

From: Predictors of hospital surface contamination with Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: patient and organism factors

 

Contaminated (%)

Non- contaminated (%)

Crude OR (95%CI)

P value

Room cleaned

3/26 (11.5)

20/112 (17.9)

0.60 (0.13–2.40)

0.57

Median visit number (IQR)

3 (1–9)

4 (2–8)

0.59

ESBL-KP

25/26 (96.2)

61/112 (54.5)

20.90 (2.85–428.64)

<0.0001

CDS-ID ≥ 1

22/26 (84.6)

86/112 (76.8)

1.66 (0.48–6.29)

0.44

Median age (IQR)

75 (62–86)

66 (48–81)

0.05

Male patient

22/26 (84.6)

51/112 (45.5)

6.58 (1.97–24.24

<0.0001

Patient 4

10/26 (38.5)

15/112 (13.4)

4.04 (1.40–11.72)

0.008

Patient 1

6/26 (23.1)

0/112 (0)

<0.0001

Antibiotic exposure

11/26 (42.3)

79/112 (70.5)

0.31 (0.12–0.80)

0.01

Carbapenem exposure

3/26 (11.5)

40/112 (35.7)

0.24 (0.05–0.90)

0.02

IDC

14/26 (53.8)

26/112 (23.2)

3.86 (1.46–10.29)

0.003

Diarrhoea

8/26 (30.8)

12/112 (10.7)

3.70 (1.18–11.58)

0.025

Clinical specimen ESBL-E

14/26 (53.8)

51/112 (45.5)

1.40 (0.55–3.56)

0.52

Clinical infection

3/26 (11.5)

34/112 (30.4)

0.30 (0.07–1.15)

0.05

Isolation from wound swab

12/26 (46.2)

33/112 (29.5)

2.05 (0.79–5.34)

0.11

Isolation from urine

2/26 (7.7)

11/112 (9.8)

0.77 (0.11–4.05)

1.0

  1. “IQR” = interquartile range; “Clinical Specimen ESBL-E” = at least one positive clinical specimen culture positive with ESBL-E.